This activity is designed for primary care clinicians (MDs, DOs, NPs, PAs, nurses, community pharmacists) involved in the care of people with obesity.
Obesity, obesity management, MASLD, MASH, cardiovascular disease
Executive Director of Clinical Education for the Obesity Medicine Association and Chair & Associate Professor of Family Medicine at Campbell University School of Medicine
BioNicholas Pennings, DO DABOM, MFOMA, FACOFP, FAAFP, is board certified with dual fellowship designation in Family Medicine and master fellowship designation in Obesity Medicine. He is Professor of Family Medicine at the Jerry M. Wallace School of Osteopathic Medicine at Campbell University. In addition, he serves as Executive Director of Clinical Education for the Obesity Medicine Association. He is a graduate of the Philadelphia College of Osteopathic Medicine and completed his family medicine residency at Metropolitan Hospital - Parkview Division. Dr. Pennings is a champion for advancing the education of health professionals through the development of core competencies in obesity medicine education and incorporation obesity education into medical education via live and virtual platforms.
Dr. Pennings is an independent contractor for Medifast, a consultant for Abbott, and a speaker for Novo Nordisk. All financial relationships have been mitigated. All Planners have no relevant financial relationships with ineligible companies to disclose.
1. | Develop individualized treatment plans for obesity management, integrating evidence-based guidelines, pharmacological therapies, and lifestyle modifications with consideration of comorbidities |
1. | Develop individualized treatment plans for obesity management, integrating evidence-based guidelines, pharmacological therapies, and lifestyle modifications with consideration of comorbidities |
Title
Obesity and Obstructive Sleep Apnea
Program Description
Obesity currently affects more than 2 in 5 adults in the United States and demonstrates significant associations with cardiovascular disease, type 2 diabetes (T2D), metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH), osteoarthritis, sleep disorders, and reproductive health complications. Obesity care continues to evolve with advancing treatment options, emerging best practices in comorbidity management, and evidence-based guidance on patient-centered approaches, creating new opportunities to improve outcomes for patients living with obesity.
Learning Objectives:
At the end of this activity, learners should be able to:
Develop individualized treatment plans for obesity management, integrating evidence-based guidelines, pharmacological therapies, and lifestyle modifications with consideration of comorbidities
Target Audience
This activity is designed for primary care clinicians (MDs, DOs, NPs, PAs, nurses, community pharmacists) involved in the care of people with obesity.
Participation and Credit:
Learners must complete the educational content online, completing pre- and post-assessments and app learning activities. A certificate will be available to you at the end of this activity. You may print the certificate, but you cannot alter it. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Unlabeled Use Disclosure:
This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), and the curriculum clearly indicates this fact.
Support:
Supported by an unrestricted educational grant from Novo Nordisk.
Fee:
There is no charge for this activity.
Cultural/Linguistic Competency:
CAFP policy and California state law require that each learning activity have elements of cultural and linguistic proficiency included in the content. The definition of cultural and linguistic competency is the ability and readiness of health care providers and health organizations to humbly and respectfully demonstrate, effectively communicate, and tailor delivery of care to patients with diverse values, beliefs, identities, and behaviors, in order to meet patients’ social, cultural, and linguistic needs as it relates to patient health. This activity meets these requirements.
Implicit Bias:
CAFP policy and California state law require that all CME activities comprising a patient care element include either (1) examples of how implicit bias affects perceptions and treatment decisions of physicians and surgeons, leading to disparities in health outcomes and/or (2) strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics. This activity meets these requirements.
Privacy Policy:
The California Academy of Family Physicians (CAFP) is committed to protecting the privacy of its members and customers. CAFP maintains safeguards to store and secure information it has about members and customers. The safeguards may be physical, electronic or procedural. For more information, contact cafp@familydocs.org.
Questions:
For questions regarding the content of this activity or for technical assistance, contact cafp@familydocs.org.
The CAFP has made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the learner is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Any medications or treatment methods suggested in this CME activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
Copyright:
© 2025 California Academy of Family Physicians. No part of this activity may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embedded in articles or reviews.
Accreditation:
The AAFP has reviewed Obesity and Obstructive Sleep Apnea and deemed it acceptable for up to 0.25 Enduring Materials, Self-Study AAFP Prescribed credit(s). Term of Approval is from 10/06/2025 to 10/05/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Faculty & disclosure:
Faculty & Faculty Advisory Panel
Ecler Jaqua, MD, MBA, FAAFP, AGSF, FACLM, AAHIVS, DipABOM
Dr. Jaqua has no relevant financial relationships with ineligible companies.
Nicholas Pennings, DO, MFOMA, FACOFP, FAAFP
Dr. Pennings is a consultant for Abbott and an independent contractor for Medifast, and a speaker for Novo Nordisk. These relevant financial relationships have been mitigated.
Additional Content Contributors
Kimberly Casteline, PhD
Dr. Casteline has no relevant financial relationships with ineligible companies.
Steven Haimowitz, MD
Dr. Haimowitz has no relevant financial relationships with ineligible companies.
Laurie Isenberg, MA, MILS, CHCP
Ms. Isenberg has no relevant financial relationships with ineligible companies.
Anne Jacobson
Ms. Jacobson has no relevant financial relationships with ineligible companies.
Renee Wadsworth
Ms. Wadsworth has no relevant financial relationships with ineligible companies.
Conflict of Interest Statements:
The CAFP Committee on Continuing Professional Development is responsible for management and resolution of conflict for any individual who may have influence on content, who has served as faculty, or who may produce or help produce CME/CPD content for the CAFP.
Management/Resolution may include learner notification, peer review of content before presentation, changing topics, or even dismissing a potential faculty member.
It is the policy of the CAFP to ensure independence, balance, objectivity, scientific rigor, and integrity in all continuing education activities. All individuals with potential to influence the content of this program have submitted Conflict of Interest declarations that have been reviewed according to policy. Learner notification of declarations is included. All individuals with potential conflicts have been contacted by CAFP staff or CCPD members, and issues of conflict have been discussed, managed, and resolved.
COURSE VIEWING REQUIREMENTS
Supported Browsers: Microsoft Edge Google Chrome 60 or higher Mozilla Firefox 60 or higher Apple Safari 11.0 or higher For video, install the latest version of Quicktime. | Supported Phones & Tablets: iOS 9.3 and higher Android 7.0 (Nougat or higher) Microsoft Windows 8 Chrome OS |
Additional Recommendations and Requirements | |
Display Resolution & Color Depth | Resolution - 960 X 768 minimum - 1024 X 768 recommended min. Color Depth - 8 bits (256 colors) minimum - 16 bits (High colors) minimum |
Audio | - Microphone - Speakers or headphones - Audio recording support |
Word Processing | Software that can open, modify, and save documents in Rich Text Format (RTF). Microsoft Word and PowerPoint are recommended. |